🇺🇸 Chemotherapy drug in United States
51 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 51
Most-reported reactions
- Pyrexia — 11 reports (21.57%)
- Nausea — 8 reports (15.69%)
- Chills — 5 reports (9.8%)
- Rash Generalised — 5 reports (9.8%)
- Disease Progression — 4 reports (7.84%)
- Malaise — 4 reports (7.84%)
- Pain In Extremity — 4 reports (7.84%)
- Pulmonary Embolism — 4 reports (7.84%)
- Abdominal Pain Upper — 3 reports (5.88%)
- Asthenia — 3 reports (5.88%)
Other Oncology approved in United States
Frequently asked questions
Is Chemotherapy drug approved in United States?
Chemotherapy drug does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Chemotherapy drug in United States?
University Hospital, Strasbourg, France is the originator. The local marketing authorisation holder may differ — check the official source linked above.